Background {#Sec1}
==========

Weaning patients off endotracheal positive-pressure ventilation involves two steps: separation of the patient from the ventilator and extubation. The day of extubation is a critical time during an intensive care unit (ICU) stay, as extubation failure occurs in 10--20% of patients and is associated with up to 50% hospital mortality \[[@CR1]--[@CR6]\]. There is some evidence that extubation failure can directly worsen patient outcomes independently of underlying illness severity \[[@CR5]\]. Several factors may contribute to extubation failure, including cough impairment and presence of thick and/or excessive mucus, in addition to hypoventilation \[[@CR4]\]. Cough assistance and noninvasive mechanical ventilation (NIV) can help to prevent post-extubation respiratory failure. However, as these techniques are time-consuming, criteria for selecting those patients most likely to benefit would be useful. Ideally, these criteria would be objective, easily measured parameters obtained immediately before and/or after extubation. Adequate respiratory muscle strength is essential to generate the pressures and flows needed to clear airway secretions during coughing. Accordingly, peak cough expiratory flow (PCEF) was found in many studies to predict successful decannulation and extubation \[[@CR7]--[@CR12]\]. However, the tracheal tube can alter PCEF values via two mechanisms: it elevates airway resistance \[[@CR13]\]; and it eliminates the role of the glottis in coughing \[[@CR14]\].

Here, our objective was to evaluate the accuracy of parameters easily collected before versus after extubation in predicting the risk of post-extubation respiratory failure requiring, at best, NIV and/or mechanical cough assistance and, at worst, reintubation. We assessed cough performance and other easily collected respiratory parameters obtained before and after extubation, with the goal of determining which parameters and measurement conditions best identified patients who would require NIV and/or mechanical cough assistance after extubation.

Methods {#Sec2}
=======

Study population {#Sec3}
----------------

We conducted a multicenter, prospective, observational study in two university-affiliated hospitals (Caen and Garches) and one general hospital (Roanne) in France from April 2012 through April 2015. The appropriate ethics committee (CPP Nord-Ouest III) approved the study (\#2011-A00849-32), which was registered on ClinicalTrials.gov (\#NCT01564745). All patients provided written informed consent.

Patients 18 years of age or older and sufficiently cooperative without sedation were eligible if they were admitted to the ICU and received invasive mechanical ventilation (MV) for at least 72 h then passed a weaning test performed according to recommendations \[[@CR4], [@CR15], [@CR16]\]. Exclusion criteria were previous long-term NIV at home and unavailability of an lung function test (LFT) technician.

Study procedures {#Sec4}
----------------

Weaning from the ventilator was performed following a standardized protocol. Patients were screened daily for predefined weaning-readiness criteria, i.e., improvement in clinical signs, peripheral capillary oxygen saturation (SpO~2~) \> 92% with fraction of inspired oxygen \< 50% and positive end-expiratory pressure \< 5 cm H~2~O, no infusion of vasopressor agents or sedatives, and adequate responses to simple commands. When these criteria were met, a spontaneous breathing test (SBT) was performed, by having the patient either breathe spontaneously from the ventilator on a T piece or receive pressure-support ventilation with an inspiratory pressure of 7 cmH~2~O and zero end-expiratory pressure. The test was interrupted if any of the following signs of poor tolerance was observed: respiratory rate \> 35/min, SpO~2~ \< 90%, heart rate \> 140/min, and arterial systolic blood pressure \> 180 mmHg or \< 90 mmHg. Patients who successfully completed the test were considered for a trial of extubation. Decisions to perform a cuff-leak test and/or give corticosteroid therapy were based on standard practice at each study center.

Patients who passed an SBT and were considered for extubation underwent lung function testing (LFT) (see Additional file [1](#MOESM1){ref-type="media"}). After extubation, the patients breathed spontaneously with an oxygen flow titrated to maintain SpO~2~ \> 90%.

Physicians were blinded to LFT results. Patients were followed until ICU discharge or death.

Lung function testing (LFT) {#Sec5}
---------------------------

LFT was repeated after extubation provided and there was no laryngeal edema (see Additional file [1](#MOESM1){ref-type="media"}).

Clinical data {#Sec6}
-------------

At ICU admission, we recorded the following: comorbidities, MV duration at inclusion, number of tracheal aspirates within 24 h before extubation, Glasgow Coma Scale score, Medical Research Council (MRC) scale combined score for muscle strength \[[@CR17]\], and Borg Scale \[[@CR18]\] score for subjective dyspnea.

Extubation care and definitions {#Sec7}
-------------------------------

According to guidelines, patients were extubated by the physician if they passed an SBT \[[@CR4], [@CR15], [@CR16]\]. We evaluated the accuracy of easily collected parameters obtained before or just after extubation in predicting weaning failure defined as a need for NIV and/or mechanical cough assistance and/or reintubation within 48 h after extubation.

Patients received NIV if they met at least one of the following predefined criteria: respiratory rate \> 30 breaths/min; SpO~2~ \< 90%; ≥ 20% variation in heart rate or blood pressure; clinical signs of respiratory distress (i.e., cyanosis, sweating, involvement of accessory respiratory muscles, paradoxical abdominal motion, consciousness impairment); PaO~2~ \< 60 mm Hg with ≥ 6 L/min O~2~; and hypercapnia with respiratory acidosis (i.e., PaCO~2~ \> 45 mm Hg and pH \< 7.35). All patients received chest physiotherapy twice daily to promote secretion clearance, with deep inspiration and manual cough assistance. Mechanical cough assistance was used, alone or with NIV, when conventional chest physiotherapy failed to prevent secretion accumulation with severe hypoxemia defined as SaO~2~ \< 90% with ≥ 6 L/min O~2~ or FiO~2~ \> 50%. Reintubation was considered when there was no improvement within 2 h and was performed according to guidelines \[[@CR15], [@CR16]\].

Statistical analysis {#Sec8}
--------------------

Quantitative variables were described as mean ± SD and qualitative variables as number (%). To compare demographics, clinical data, and LFT results between groups with and without weaning failure as defined above (NIV and/or mechanical cough assistance and/or reintubation, within 48 h after extubation), we used the Chi-square test for categorical variables and the Wilcoxon *t* test for quantitative co-variables. Multivariate logistic regression was performed to identify pre-extubation measurements independently associated with weaning failure. The close correlations among respiratory parameters precluded the use of a single multivariate model. Therefore, we built a separate multivariate logistic regression model to assess the ability of each LFT variable to predict weaning failure. All models were adjusted for MV duration (\< 7 vs. ≥ 7 days), MRC scale score (\< 48 vs. ≥ 48), and previous chronic respiratory failure. Model discrimination was assessed by the concordance index (c-index) and plotted on a receiver operating characteristic (ROC) curve. For each LFT variable, we identified the cutoff that maximized the Youden index, and we computed the sensitivity and specificity of this cutoff for predicting weaning failure. In addition, correlations between each LFT parameter before and after extubation were assessed by Pearson's correlation coefficient.

All *P* values were two-tailed with no adjustment for multiple comparisons. *P* values \< 0.05 were considered significant. The statistical analyses were performed using SAS statistical software, version 9.4 (SAS Institute Inc., Cary, NC, USA).

Results {#Sec9}
=======

Study population {#Sec10}
----------------

Among 3458 patients admitted to the study ICUs, 730 received MV for more than 72 h and were then extubated; among these, 130 were included in the study (Fig. [1](#Fig1){ref-type="fig"}). Table [1](#Tab1){ref-type="table"} reports their main characteristics at ICU admission. At study inclusion, mean values for ICU stay and MV duration were both 11.0 ± 4.2 days. Five patients were excluded from the analysis because they required immediate reintubation due to either laryngeal edema (*n* = 3) or acute coma (*n* = 2) and consequently could not undergo post-extubation testing. Fig. 1Flowchart of the study Table 1Characteristics of the patients at ICU admissionParametersMean ± SD or *n* (%)Total (*n* = 130) Age (years)59.4 ± 15.6 Male71 (54.6) BMI27.2 ± 6.7 Chronic disease  Chronic obstructive pulmonary disease16 (12.3%)  Chronic restrictive pulmonary disease11 (8.4%)  Chronic heart disease13 (10%)  SAPS II45 ± 21  SOFA7 ± 5 Main reason for ICU admission  Acute respiratory failure91 (70)  Heart failure14 (10.8)  Neurologic failure9 (6.9)  Septic shock12 (9.2)  Postoperative1 (0.8)  Other3 (2.3)*BMI* body mass index, *SAPS II* Simplified Acute Physiology Score II \[[@CR30]\], *SOFA* Sequential Organ Failure Assessment

After extubation, 36 patients required curative NIV, including 7 who also needed mechanical cough assistance, and 8 required only mechanical cough assistance. Reintubation was performed within 2 days after extubation in 6 patients and on day 6 in 1 patient. All reintubated patients received NIV within 2 days following extubation, and none died in the ICU. Patients who were reintubated were significantly younger and had a lower BMI than those who received only NIV and/or mechanical cough assistance.

Comparison of lung function parameters before and after extubation {#Sec11}
------------------------------------------------------------------

Vital capacity (VC), forced vital capacity (FVC), peak expiratory flow (PEF), and PCEF were significantly higher after than before extubation. Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) were significantly higher before than after extubation (all *P* values \< 0.001). As shown in Table [2](#Tab2){ref-type="table"}, the pre-extubation and post-extubation values correlated with each other for all variables (all *P* values \< 0.0001); the correlation was strongest for FVC (*R* = 0.89). Table 2Correlations between physiological parameters before and after extubationVC\
Before extubationFVC\
Before extubationMIP\
Before extubationMEP\
Before extubationPEF\
Before extubationPECF\
Before extubationVC\
After extubation *R*0.61 *P* value\< *0.0001*FVC\
After extubation *R*0.89 *P* value\< *0.0001*MIP\
After extubation *R*0.70 *P* value\< *0.0001*MEP\
After extubation *R*0.66 *P* value\< *0.0001*PEF\
After extubation *R*0.60 *P* value\< *0.0001*PCEF\
After extubation *R*0.58 *P* value\< *0.0001*For each parameter, the table shows the correlation coefficient and *P* valueItalics indicate significant data*VC* vital capacity, *FVC* forced vital capacity, *MIP* maximal inspiratory pressure, *MEP* maximal expiratory pressure, *PEF* peak expiratory flow, *PCEF* peak cough expiratory flow

Comparison of patients who did (*n* = 44) and did not (81) require NIV or mechanical cough assistance after extubation {#Sec12}
----------------------------------------------------------------------------------------------------------------------

As shown in Table [3](#Tab3){ref-type="table"}, the group that required post-extubation NIV or mechanical cough assistance had a significantly higher proportion of patients with chronic respiratory disease, longer ICU stay and MV durations at study inclusion, and lower MRC scores compared to the other group.Table 3Univariate analysesParametersNo NIV or mechanical cough assistance after extubation (*n* = 81)NIV or mechanical cough assistance after extubation*P* value\*Mean ± SD or *n* (%)All patients\
(*n* = 44)\
Mean ± SD or *n* (%)Patients who required\
NIV (*n* = 36)\
Mean ± SD or *n* (%)Patients who required\
Mechanical cough assistance (*n* = 8)\
Mean ± SD or *n* (%)Age, years58.8 ± 14.859.8 ± 16.459.6 ± 15.760.8 ± 20.30.71SOFA at admission7.7 ± 57.2 ± 4.27.5 ± 4.15.9 ± 4.80.59Coma Glasgow Scale score15 ± 015 ± 015 ± 015 ± 01.00Chronic respiratory failure11 (14%)14 (32%)14 (39%)0*0.015*Chronic heart disease10 (12%)3 (7%)3 (8%)00.34Duration of MV, days12.7 ± 8.817.8 ± 15.617.4 ± 14.419.8 ± 21.2*0.02*Diameter of the endotracheal tube, mm7.5 ± 0.37.4 ± 0.37.3 ± 0.37.6 ± 0.30.17MRC score51.1 ± 1243 ± 15.543.2 ± 12.242.2 ± 12.2*0.004*Tracheal aspiration before extubation (*n*/24 h)7.8 ± 37.7 ± 2.77.7 ± 2.57.6 ± 3.60.89Respiratory rate (breaths/min)23.2 ± 11.824.5 ± 5.624.8 ± 5.923.4 ± 4.20.50Borg Scale score (/10)1.9 ± 2.32.1 ± 2.22 ± 22.3 ± 3.50.60PaCO~2~ before extubation5.0 ± 0.65.6 ± 15.8 ± 14.9 ± 0.7*0.00007*VC (mL) before extubation1574 ± 4981281 ± 5361220 ± 5131558 ± 586*0.003*FVC (mL) before extubation1571 ± 5201146 ± 4571121 ± 4641257 ± 439*0.00002*MIP (cmH~2~O) before extubation37 ± 1531 ± 1532 ± 1526 ± 12*0.025*MEP (cmH~2~O) before extubation53 ± 2841 ± 2444 ± 2530 ± 16*0.021*PEF (L/min) before extubation80 ± 3262 ± 3060 ± 2971 ± 36*0.004*PCEF (L/min) before extubation97 ± 3672 ± 3371 ± 3375 ± 36*0.0003*VC (mL) after extubation1838 ± 6371364 ± 4991343 ± 5111463 ± 464*0.00017*FVC (mL) after extubation1766 ± 5541284 ± 4331284 ± 4401282 ± 441*0.00003*MIP (cmH~2~O) after extubation28 ± 1323 ± 1123 ± 1122 ± 10*0.07*MEP (cmH~2~O) after extubation43 ± 2229 ± 1731 ± 1721 ± 12*0.002*PEF (L/min) after extubation142 ± 77107 ± 63109 ± 6695 ± 47*0.02*PCEF (L/min) after extubation166 ± 76107 ± 66110 ± 7294 ± 39*0.0001*Italics indicate significant data*SOFA* Sequential Organ Failure Assessment, *MRC* Medical Research Council sum score, *PaO*~*2*~ partial pressure of O~2~ in arterial blood, *PaCO*~*2*~ partial pressure of CO~2~ in arterial blood, *FiO*~*2*~ fraction of inspired O~2~, *VC* vital capacity, *FVC* forced vital capacity, *MIP* maximal inspiratory pressure, *MEP* maximal expiratory pressure, *PEF* peak expiratory flow, *PCEF* peak cough expiratory flow, *NS* nonsignificant\**P* values compare patients with and without NIV and/or mechanical cough assistance

By univariate analysis, pre-extubation LFT variables significantly associated with post-extubation NIV and/or mechanical cough assistance were PaCO~2~, VC, FVC, MIP, MEP, PEF, and PCEF (Table [2](#Tab2){ref-type="table"}). Post-extubation LFT variables significantly associated with post-extubation NIV and/or mechanical cough assistance were VC, FVC, MEP, PEF, and PCEF (Table [2](#Tab2){ref-type="table"}).

By multivariate logistic regression adjusted for MV duration, MRC score, and the existence of chronic respiratory failure, variables independently associated with post-extubation NIV and/or mechanical cough assistance were VC, FVC, MIP, MEP, PEF, and PCEF (Table [4](#Tab4){ref-type="table"}).Table 4Multivariate analysis of extubation predictorsModelOdds Ratio (IC 95%)*P* valueModel 1\
FVC0.998 (0.997--0.999)*0.0005*Model 2\
VC0.999 (0.998--1.000)*0.0078*Model 2\
MIP0.973 (0.947--1.000)*0.05*Model 3\
MEP0.983 (0.967--0.999)*0.043*Model 4\
PEF0.980 (0.965--0.996)*0.012*Model 5\
PCEF0.980 (0.967--0.993)*0.0022*One separate model was used for each predictor. All the models were used in multivariable analysis adjusting for the duration of mechanical ventilation (\< 7-day vs. 7 days or more), chronic respiratory failure (Yes/No) and MRC (\< 48 vs. 48 or more). An odds ratio (OR) \> 1 signified an increased probability of necessity of mechanical ventilator assistanceItalics indicate significant data*VC* vital capacity, *FVC* forced vital capacity, *MIP* maximal inspiratory pressure, *MEP* maximal expiratory pressure, *PEF* peak expiratory flow, *PCEF* peak cough expiratory flow

ROC curve analysis of performance of the independent predictors {#Sec13}
---------------------------------------------------------------

As shown in Fig. [2](#Fig2){ref-type="fig"}, the areas under the ROC curves for pre-extubation PCEF, PEF, FVC, MIP, and MEP were 0.71, 0.67, 0.76, 0.61, and 0.69, respectively. The cutoffs that performed best in predicting post-extubation NIV and/or mechanical cough assistance were 85 L/min for PCEF, 62 L/min for PEF, and 1412 mL for FVC. The PCEF cutoff had 74% sensitivity and 62% specificity, the PEF cutoff 51% sensitivity and 76% specificity, and the FVC cutoff 65% sensitivity and 81% specificity.Fig. 2Receiver operating characteristic (ROC) curves for data recorded before extubation: peak cough expiratory flow (PCEF), peak expiratory flow (PEF), forced vital capacity (FVC), slow VC, and maximal inspiratory (MIP) and expiratory (MEP) mouth pressures. AUC, area under the ROC curve

As shown in Fig. [3](#Fig3){ref-type="fig"}, the areas under the ROC curves for post-extubation PCEF, PEF, FVC, MIP, and MEP were 0.76, 0.68, 0.80, 0.62, and 0.73, respectively. The cutoffs that performed best in predicting post-extubation NIV and/or mechanical cough assistance were 113 L/min for PCEF, 151 L/min for PEF, and 1430 mL for FVC. The PCEF cutoff had 56% sensitivity and 90% specificity, the PEF cutoff 57% sensitivity and 76% specificity, and the FVC cutoff 72% sensitivity and 85% specificity.Fig. 3Receiver operating characteristic (ROC) curves for data recorded after extubation: peak cough expiratory flow (PCEF), peak expiratory flow (PEF), forced vital capacity (FVC), slow VC, and maximal inspiratory (MIP) and expiratory (MEP) mouth pressures AUC, area under the ROC curve

Discussion {#Sec14}
==========

The main finding from this study is that the parameter with the closet correlation between pre- and post-extubation values was FVC. FVC may be an objective marker for identifying patients in whom NIV and/or mechanical cough assistance might prevent reintubation. Hypoventilation, cough impairment, and presence of thick and/or excessive mucus can contribute to extubation failure. Most of the previous studies evaluating cough efficiency before extubation focused on PCEF. However, the PCEF cutoffs varied widely \[[@CR9], [@CR12]\], perhaps due to differences in study populations and MV durations. Moreover, the diversity of devices used to measure PCEF, presence of a cannula used to bypass the upper airway \[[@CR19]\], and differences in the degree of patient coordination and cooperation during measurements may influence the results \[[@CR12], [@CR20], [@CR21]\]. In our study, the optimal PCEF cutoff was 85 L/min before extubation and 113 L/min just after extubation. Our pre-extubation PCEF cutoff was higher than in earlier studies. However, our objective was to predict a need for post-extubation NIV and/or mechanical cough assistance, whereas previous studies \[[@CR12], [@CR20]\] sought to predict reintubation. Furthermore, the correlation between pre- and post-extubation PCEF values was weak. Several hypotheses can be suggested to explain this finding. The inability of intubated patients to close their glottis limits the pressure generated during coughing and therefore limits the PCEF values compared to those measured without the tube. Also, resistances are higher with than without the endotracheal tube. Finally, in a recent study in tracheostomized patients with neuromuscular disease, PCEF was higher after than before decannulation \[[@CR13], [@CR22]\].

Interestingly, Bach and Saporito \[[@CR7]\] were the first to use PCEF as a criterion for extubation in patients with neuromuscular disease. However, they measured PCEF immediately after extubation and enhanced performance by combining maximal insufflation with an abdominal thrust timed to glottis opening. The results showed that PCEF \> 160 L/min predicted successful extubation. More recently, they challenged their previous PCEF cutoff by demonstrating that professionals who had extensive experience with the noninvasive management of respiratory failure were able to extubate continuously ventilator-dependent patients who had severe cough impairment \[[@CR8]\]. Finally, they demonstrated that using noninvasive techniques to improve cough performance and minute ventilation could drastically modify the outcomes of extubated patients, including those dependent on a ventilator \[[@CR8]\]. These studies and our data suggest that identifying both the optimal PCEF value and the best PCEF measurement conditions in critically ill patients remains challenging because many factors, including the use of assistive devices, can influence the measurement result.

We tested the usefulness of various LFT parameters for evaluating voluntary cough at the bedside. PCEF and PEF were significantly higher in the successfully extubated group, and low PCEF and PEF values independently predicted post-extubation NIV and/or mechanical cough assistance.

As described previously \[[@CR23]--[@CR25]\], expiratory muscle strength as assessed by the MEP correlated with PCEF. MIP and MEP measurements require a static maneuver with maintenance of a maximal pressure for at least 1.5 s \[[@CR26]\]. Nevertheless, contrary to FVC and PCEF, MIP and MEP cannot be measured easily in all mechanically ventilated patients without a specific device.

Our study provides the first evidence that FVC correlates well with PCEF and outperforms PCEF for predicting a need for NIV and/or mechanical cough assistance after extubation. In addition, FVC was the parameter least affected by the presence of a tracheal tube, so that pre-extubation FVC \< 1420 mL was 64% sensitive and 81% specific, with improvements to 72 and 85%, respectively, when FVC remained \< 1420 mL after extubation. This is not surprising given that FVC diminishes only in the event of air trapping, which is generally due to peripheral airway obstruction and not to increased central airway resistance due, for instance, to a tracheal tube.

Several limitations of our study should be addressed. First, we included only those patients who were sufficiently cooperative and were extubated at a time when the technician was available for pre-extubation LFT. This requirement decreased the number of included patients but allowed the physicians to remain blinded to LFT findings, thereby minimizing bias. Thus, of the 730 patients extubated during the study period, 130 (18%) were included. Second, we did not assess involuntary cough. However, recent work indicates that, in cooperative patients, voluntary PCEF is far more accurate than involuntary PCEF in predicting reintubation, due to underestimation of cough strength by involuntary PCEF in patients with high voluntary PCEF \[[@CR21]\]. We deliberately confined our study to cooperative patients, since we used noninvasive but volitional measurement techniques. Third, we excluded patients with MV for less than 72 h, since extubation failure is rare in this situation. Fourth, we did not measure the rapid shallow breathing index or fluid balance, two variables significantly associated with extubation failure in a previous study \[[@CR27]\]. However, all study patients passed an SBT. Surprisingly, maximal pressures decreased after extubation, whereas the other parameters increased. This finding may be ascribable to the difference in patient-measurement device interface between pre- and post-extubation \[[@CR28], [@CR29]\]. In addition, upper-airway muscle activation and coordination are usually required when using a flanged mouthpiece but are not required when a tracheal tube bypasses the upper airway, which allows the patient to concentrate the effort on the inspiratory or expiratory muscles. Finally, a tracheal tube may diminish airway compliance and, therefore, the volume change during breathing, resulting in higher pressures for the same effort. Fifth, as this study used a prospective observational design, we did not change the practices in each center regarding the use of preventive NIV. The percentage of reintubated patients was surprisingly small in our study, i.e., 3 times lower than in the study by Esteban et al. among patients receiving NIV (48 vs. 16%). This difference may be ascribable to the high prevalence in our study of patients with COPD or restrictive pulmonary disease (20.7%), who may derive particularly large benefits from NIV \[[@CR30]\]. Although ERS/ATS guidelines do not recommend using NIV to avoid reintubation in patients with overt respiratory distress and/or respiratory failure after planned extubation, this recommendation is not considered definitive and may not apply to patients with COPD \[[@CR31]\]. Furthermore, reported benefits of curative NIV include improved oxygenation and alveolar ventilation, better alveolar recruitment in patients with atelectasis, improved left ventricular function in patients with heart failure, and decreases in intrinsic PEEP and work of breathing \[[@CR32]\].

A legitimate issue is whether postponing extubation might have decreased the reintubation rate in our patients, who had longer MV durations before extubation compared to those in recent studies \[[@CR5], [@CR33], [@CR34]\]. This difference is due to the inclusion in our study of only those patients already on MV for 72 h. However, our patients were extubated as soon as the daily conventional SBT was successful, in keeping with recent guidelines about the optimal assessment of weaning readiness \[[@CR35]\].

Another factor that may have contributed to the low reintubation rate in our population is the considerable experience of our staff in the noninvasive treatment of patients with chronic and complete ventilator dependency \[[@CR36]--[@CR38]\]. We share this high level of experience with teams specialized in neuromuscular diseases \[[@CR39]\]. Moreover, the addition to NIV of mechanical insufflation-exsufflation when appropriate may have further decreased the reintubation needs, as shown in a recent randomized trial \[[@CR40]\]. Given the persistent challenges in identifying patients at high risk of post-extubation respiratory failure requiring, at best, NIV or mechanical cough assistance and, at worst, reintubation, we chose weaning failure defined as the use of NIV, cough assistance, and/or reintubation as the study endpoint.

Finally, as demonstrated by Thille et al. \[[@CR41]\] the ability of healthcare staff to predict extubation failure is poor. The results reported here should help to identify patients likely to benefit from preventive NIV or cough assistance, using simple physiological parameters. These results need to be confirmed in a large epidemiological study including clinical and physiological variables \[[@CR33]\].

Conclusion {#Sec15}
==========

In conclusion, our main finding is that FVC measurements before and after extubation are well correlated. FVC may serve as an objective predictor of post-extubation respiratory failure requiring NIV and/or mechanical cough assistance and/or reintubation in heterogeneous populations of medical ICU patients. FVC measurement may deserve consideration as an inexpensive tool to be used in combination with easily identified risk factors for assessing patients after a successful SBT, with the goal of identifying those likely to require prophylactic post-extubation NIV and/or mechanical cough assistance. However, further studies are necessary to confirm our results in different conditions and populations.

Additional file {#Sec16}
===============

[**Additional file 1:**](https://doi.org/10.1186/s13613-018-0360-3) Details on methods.
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